Korro Bio Unveils Presentations at Oligonucleotide Therapy Event
Korro Bio's Groundbreaking Presentations on RNA Editing
Recently, Korro Bio, Inc. made an exciting announcement regarding its participation at a key industry event, the 20th Annual Meeting of the Oligonucleotide Therapeutics Society. This meeting marks a significant platform for researchers and biopharmaceutical companies dedicated to advancing therapeutic applications of oligonucleotides.
Highlights of the Annual Meeting
The meeting, scheduled to take place from October 6 to 9, will feature Korro Bio's innovative research through one oral and two poster presentations. Korro is known for its commitment to developing genetic medicines that leverage the precision of RNA editing technology. This year, the meeting serves as an opportunity for the company to showcase its latest advancements and connect with experts in the field.
Focus on KRRO-110
Venkat Krishnamurthy, Ph.D., who holds the position of Senior Vice President and Head of Platform at Korro, will deliver a notable oral presentation on KRRO-110. This is the company's first candidate aimed at treating alpha-1 antitrypsin deficiency (AATD), a significant genetic disorder resulting from specific mutations in the SERPINA1 gene. The prospect of addressing such a serious condition through innovative RNA editing is particularly impressive.
Key Presentation Details
The details surrounding Dr. Krishnamurthy's oral presentation are as follows:
- Title: KRRO-110, an RNA Editing Oligonucleotide For The Treatment Of Alpha-1 Antitrypsin Deficiency (AATD)
- Date: Monday
- Time: 3:20 p.m. ET
Poster Presentations: In-Depth Analysis
In addition to the oral presentation, Korro will feature two poster presentations that delve deeper into the mechanisms and methodologies of RNA editing. These presentations are crafted to highlight Korro's cutting-edge research, showing the potential impacts of their findings on real-world applications.
First Poster Presentation
The first poster presentation, led by Agya Karki, Ph.D., focuses on the purification of human ADAR, illuminating how it enables assessment of oligo-directed RNA editing in a controlled environment. This work aims to predict the in vivo activity of the therapeutic approach.
Second Poster Presentation
The second poster, presented by Zhiji Ren, Ph.D., investigates the on-target and off-target effects of RNA editing oligonucleotides using ADAR1 chimeric enhanced cross-linking immunoprecipitation (eCLIP). This research is crucial for understanding the safety and efficacy of the editing technologies.
About Korro Bio
Korro Bio is driven by a mission to harness the power of RNA editing to create new genetic medicines that can address both rare and common diseases. Unlike traditional approaches that modify DNA, Korro’s platform edits RNA. This key difference allows for precise, temporary changes that can be more controllable and possibly better tolerated by patients in the long term. By focusing on oligonucleotide-based therapies, Korro aims to provide transformative solutions for patients through innovative delivery strategies and a robust adherence to regulatory guidelines.
Connecting with Korro Bio
To learn more about Korro Bio and its pioneering work in genetic medicine, the company can be reached at the following contact points:
Investors: IR@korrobio.com
Media Contact:
Glenn Silver
FINN Partners
Glenn.silver@finnpartners.com
Frequently Asked Questions
What is the focus of Korro Bio?
Korro Bio specializes in developing RNA editing technologies to create genetic medicines for various diseases.
When is Korro Bio's presentation scheduled?
The oral presentation will take place on Monday at 3:20 p.m. ET.
Who is the speaker for the oral presentation?
Venkat Krishnamurthy, Ph.D., will present on KRRO-110, focusing on AATD.
What are the topics of the poster presentations?
The poster presentations cover the purification of human ADAR and the effects of RNA editing oligonucleotides.
Where can I find more information about Korro Bio?
For additional details about Korro Bio's innovative work, visit their official website at korrobio.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Navigating Market Shifts: The Future of the S&P 500
- Honoring Excellence: HomeServe's Annual Contractor Awards Event
- Weave Dominates G2’s Fall Report with 21 Category Wins
- Kiely Family Acquires All Bright Electric from Woodbridge International
- Celebrate Nokian Tyres' 90th with Special Rebate Offer
- Cultivating Heritage: The Rise of 'Ruby' in Detroit
- Missouri Embraces Heggerty's Innovative Literacy Program
- ICCPP's Role in Driving Sustainable Development at GTNF 2024
- EchoStar Corp's Strategic Move with DirecTV Affects Stock
- Diane Schroeder's Transformative Co-Parenting Journey
Recent Articles
- HarborOne Bancorp Announces Dividend for Third Quarter 2024
- AMN Healthcare Announces Upcoming Earnings Conference Call
- Pacific Premier Bancorp Prepares for Third Quarter Financial Review
- Plasma Fractionation Market Projected to Reach $63.27 Billion
- VICI Properties Inc. Plans Third Quarter 2024 Earnings Report
- Cortechs.ai Partners with Ascend Imaging for Radiology Growth
- Putnam Investments Outlines Latest Distribution Rates for Funds
- FMC Corporation Partners with Ballagro to Boost Crop Protection
- Transformative Changes Needed at AGCO for Future Success
- Neeve's $15 Million Funding Boosts Smart Building Innovation
- TransPerfect Expands Capabilities with Paybooks Technologies
- WNS and Uniqus Collaborate on Sustainable Accounting Solutions
- kdc/one Expands Cosmetics Packaging through Laffon Acquisition
- Schouw & Co. Announces Progress in Share Buy-Back Plan
- Canoo's Groundbreaking Oklahoma Plant: A New Era in EVs
- Seven Hills Realty Trust Announces Q3 2024 Earnings Call Details
- ResMed Launches Innovative CPAP Mask for Enhanced Sleep Therapy
- Electrosoft Secures Major Contract with DLA for IT Services
- Advent International Welcomes Carmine Di Sibio as New Leader
- Dovetail Genomics Unveils New Service Provider Program
- Inspire Agency Partners with Ritedose Corporation for Growth
- Wispr Secures $12M Investment to Revolutionize Voice Technology
- Palisades Nuclear Plant's Historic Restart and Its Future Impact
- Revolutionary sa-mRNA COVID-19 Vaccine Shows Lasting Effects
- AT&T Sells DirecTV Stake as Dish Network Merges with DirecTV
- Alliant Insurance Services Strengthens Community Ties through IICF
- Air Products Enhances Focus on Industrial Gases with Major Sale
- Le Balt Project: Revamping Urban Rental Living Experience
- Pathward Recognized for Innovative Banking Services Excellence
- Crombie REIT Expands Portfolio with Zephyr Acquisition Strategy
- Rising Consumer Expectations for Honesty in Marketing Practices
- Altudo Partners with Shopify Plus for Innovative E-commerce Solutions
- The Stilwell Group Discusses Silvergate's Recent Annual Meeting
- United Airlines Introduces New Canned Wine Selection for Passengers
- Hollard Group Risk Partners with Sapiens for Digital Transformation
- Cox Automotive Launches Retail360: Revolutionizing Car Buying
- NeuroBo Pharmaceuticals Advances DA-1726, An Obesity Treatment
- LOBO EV Technologies Posts Impressive Earnings Growth for H1 2024
- Salinda Resort: The Ultimate Romantic Escape Awaits You
- Mercy BioAnalytics Unveils Cancer Detection Advances in Journals
- National Diversity Council Announces Transition and Legacy Efforts
- Arizona Voters Demand Strong Leadership and Effective Solutions
- Johnson & Johnson Enhances Vision with New TECNIS Odyssey Lens
- Avantor's NuSil Brand Celebrated for Process Improvement
- New Cybersecurity Insights from Recent State CISOs Survey
- Hollard Group Risk Embraces Sapiens Solutions for Efficiency
- Erste Group Downgrades Shell Amid Anticipated Oil Supply Surge
- Electrosoft Secures DLA Contract for Enhanced IT Support
- Exciting Developments at U.S. GoldMining's Whistler Project
- Inspire Agency Partners with Ritedose for Life Science Advancement